These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 3886407)

  • 21. Stimulation of dopamine D-1 receptors by SKF 38393 induces EEG desynchronization and behavioral arousal.
    Ongini E; Caporali MG; Massotti M
    Life Sci; 1985 Dec; 37(24):2327-33. PubMed ID: 3877855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In morphinised rats SKF 38393 converts dopamine D2 receptor-mediated forward locomotion into backward walking.
    Axon DI; Fletcher GH; Starr MS
    Pharmacol Biochem Behav; 1987 Jan; 26(1):45-7. PubMed ID: 3494255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of grooming and other behavioural responses to the D-1 dopamine receptor agonist SK & F 38393 and its R- and S-enantiomers in the intact adult rat.
    Molloy AG; Waddington JL
    Psychopharmacology (Berl); 1987; 92(2):164-8. PubMed ID: 3110837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A fixed interval momentary sampling method for assessing on-going behaviours induced by dopamine receptor agonists.
    Cameron DL; Crosbie J; Crocker AD
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(5):595-606. PubMed ID: 3265522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stereotyped behaviour in response to the selective D-2 dopamine receptor agonist RU 24213 is enhanced by pretreatment with the selective D-1 agonist SK&F 38393.
    Mashurano M; Waddington JL
    Neuropharmacology; 1986 Aug; 25(8):947-9. PubMed ID: 3490631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of adrenalectomy on responses mediated by dopamine D-1 and D-2 receptors.
    Faunt JE; Crocker AD
    Eur J Pharmacol; 1989 Mar; 162(2):237-44. PubMed ID: 2566498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of dopamine D1 and D2 agonists and antagonists on velocity of movement, rearing and grooming in the mouse. Implications for the roles of D1 and D2 receptors.
    Starr BS; Starr MS
    Neuropharmacology; 1986 May; 25(5):455-63. PubMed ID: 3488514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postsynaptic dopamine agonist properties of B-HT 920 as revealed by concomitant D-1 receptor stimulation.
    Pifl C; Hornykiewicz O
    Eur J Pharmacol; 1988 Jan; 146(1):189-91. PubMed ID: 3258244
    [No Abstract]   [Full Text] [Related]  

  • 29. Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors.
    Braun AR; Chase TN
    Eur J Pharmacol; 1986 Nov; 131(2-3):301-6. PubMed ID: 3493161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Behavioural evidence for the functionality of D-2 but not D-1 dopamine receptors at multiple brain sites in the 6-hydroxydopamine-lesioned rat.
    Fletcher GH; Starr MS
    Eur J Pharmacol; 1987 Jun; 138(3):407-11. PubMed ID: 2957221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavioural responses to the selective D1-dopamine receptor agonist R-SK&F 38393 and the selective D2-agonist RU 24213 in young compared with aged rats.
    Molloy AG; Waddington JL
    Br J Pharmacol; 1988 Oct; 95(2):335-42. PubMed ID: 2906555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Further evidence for two directions of D-1:D-2 dopamine receptor interaction revealed concurrently in distinct elements of typical and atypical behaviour: studies with the new enantioselective D-2 agonist LY 163502.
    Murray AM; Waddington JL
    Psychopharmacology (Berl); 1989; 98(2):245-50. PubMed ID: 2569218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions of drugs acting on central dopamine receptors and cholinoceptors on yawning responses in the rat induced by apomorphine, bromocriptine or physostigmine.
    Zarrindast MR; Poursoltan M
    Br J Pharmacol; 1989 Apr; 96(4):843-8. PubMed ID: 2663110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New putative selective agonists at the D-1 dopamine receptor: behavioural and neurochemical comparison of CY 208-243 with SK&F 101384 and SK&F 103243.
    Murray AM; Waddington JL
    Pharmacol Biochem Behav; 1990 Jan; 35(1):105-10. PubMed ID: 1969161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Behavioral and biochemical expression of D1-receptor supersensitivity following SCH 23390 repeated administrations.
    Gandolfi O; Roncada P; Dall'Olio R; Montanaro N
    Brain Res; 1988 Jul; 455(2):390-3. PubMed ID: 2969768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperactivity induced by stimulation of separate dopamine D-1 and D-2 receptors in rats with bilateral 6-OHDA lesions.
    Arnt J
    Life Sci; 1985 Aug; 37(8):717-23. PubMed ID: 3927097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of SCH 23390, a DA1-receptor antagonist, on the behavioural responsiveness to small and large doses of apomorphine in rats.
    Cuomo V; Cagiano R; Colonna M; Renna G; Racagni G
    Neuropharmacology; 1986 Nov; 25(11):1297-300. PubMed ID: 2948132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The discriminative stimulus properties of the D-1 agonist SK&F 38393 and the D-2 agonist (-)-NPA are mediated by separate mechanisms.
    Arnt J
    Life Sci; 1988; 42(5):565-74. PubMed ID: 2963185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential inhibition by dopamine D-1 and D-2 antagonists of circling behaviour induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions.
    Arnt J; Hyttel J
    Eur J Pharmacol; 1984 Jul; 102(2):349-54. PubMed ID: 6148252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postsynaptic dopamine (DA) receptor stimulator properties of the putative DA autoreceptor-selective agonist B-HT 920 uncovered by co-treatment with the D-1 agonist SK&F 38393.
    Hjorth S; Carlsson A
    Psychopharmacology (Berl); 1987; 93(4):534-7. PubMed ID: 2893419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.